Optimizing Cotreatment of HCV and HIV Infection

This comprehensive program on managing HCV/HIV coinfection features an Interactive Decision Support Tool to compare your treatment choices with guideline recommendations, an educational module with accompanying downloadable slideset for fast and efficient learning, and more.
Mark S. Sulkowski, MD

Module

Learn expert insights on choosing DAAs and ART for patients with HCV/HIV coinfection in this succinct and focused module.

Mark S. Sulkowski, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.2 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: July 20, 2018 Expired: No longer available for credit

Gain expert perspective on selecting optimal DAA and ARV combinations for patients with HCV/HIV coinfection in this downloadable slideset.

Mark S. Sulkowski, MD Released: July 20, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an independent educational grant from
Gilead Sciences

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue